Welcome to our dedicated page for Applied Uv Series A Preferred Stock news (Ticker: AUVIP), a resource for investors and traders seeking the latest updates and insights on Applied Uv Series A Preferred Stock stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Applied Uv Series A Preferred Stock's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Applied Uv Series A Preferred Stock's position in the market.
Applied UV, Inc. (AUVI) announced a cash dividend of $0.21875 per share for its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). This dividend will be paid on or about January 16, 2023, to shareholders of record as of the close of business on January 3, 2023. The company specializes in pathogen elimination technologies, offering solutions for various sectors, including healthcare and public venues. Its products have been adopted by significant organizations globally, enhancing its credibility in the field of infection control.
Applied UV, Inc. (NASDAQ: AUVI) has declared a cash dividend of
Applied UV has announced a cash dividend of $0.21875 per share for its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). The dividend will be distributed on or about November 15, 2022, to shareholders on record by the close of business on November 3, 2022. This action underscores the company's commitment to returning value to its investors while focusing on innovative pathogen elimination technologies aimed at various markets.
Applied UV, Inc. (AUVI) announced a cash dividend of
Applied UV has announced a cash dividend of $0.21875 per share to holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (NASDAQ: AUVIP). The dividend will be paid on or about September 15, 2022, to shareholders on record as of the close of business on September 2, 2022. This dividend reflects the company's commitment to delivering value to its investors while maintaining a focus on advancing pathogen elimination technology across various markets.
Applied UV has announced a cash dividend of $0.21875 per share for holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). The dividend is scheduled for payment on or about August 15, 2022, to holders of record as of August 3, 2022. As a pathogen elimination technology company, Applied UV focuses on infection control across various sectors, utilizing advanced UVC technology for air purification and surface disinfection in healthcare and commercial settings.
Applied UV, Inc. (AUVI) has announced a cash dividend of $0.21875 per share for holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). This dividend will be payable on or about July 15, 2022, to shareholders on record as of the close of business on July 1, 2022. The company focuses on pathogen elimination technologies that leverage UVC light for surface cleaning and air purification, supporting markets like healthcare and hospitality.
Applied UV, Inc. (AUVI) has announced a cash dividend of $0.21875 per share for holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). The dividend will be paid on or about June 15, 2022, to shareholders of record at the close of business on June 3, 2022.
The company's technology focuses on pathogen elimination using UVC light and air purification solutions, aiming to address infection control across various sectors including healthcare and hospitality.
Applied UV, Inc. (AUVI) has announced a cash dividend of $0.21875 per share for its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). This return of capital is scheduled for payment on May 16, 2022, to shareholders on record as of the close of business on May 4, 2022. The company specializes in pathogen elimination technology using UVC light and bioconversion methods for air purification, targeting markets such as healthcare and hospitality.
Applied UV, Inc. (Nasdaq: AUVI) has authorized a cash dividend of